SCHEMBL4925691

SCHEMBL4925691

O=C(CCCCCNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)NC(=O)c1ccccc1)NO

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.60
HDAC1 Q13547 10/20 0.58
HDAC3 O15379 8/20 0.58
HDAC2 Q92769 8/20 0.58
NCOR2 Q9Y618 3/20 0.58
HDAC8 Q9BY41 6/20 0.57
HDAC4 P56524 4/20 0.57
HDAC7 Q8WUI4 4/20 0.57
HDAC10 Q969S8 4/20 0.57
HDAC11 Q96DB2 4/20 0.57
HDAC6 Q9UBN7 4/20 0.57
HDAC9 Q9UKV0 4/20 0.57
HDAC5 Q9UQL6 4/20 0.57
BMP1 P13497 1/20 0.57
MMP2 P08253 1/20 0.57
MMP7 P09237 1/20 0.57
MMP8 P22894 1/20 0.57
CTSL P07711 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14260749 1.00 MMP1 (0.60) MMP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL4925285 1.00 MMP1 (0.60) MMP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL14260750 1.00 MMP1 (0.60) MMP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL14260672 0.89 HDAC3 (0.60) MMP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL1233724 0.84 HDAC3 (0.67) MMP1HDAC1HDAC3HDAC2HDAC8
SCHEMBL7138854 0.84 HDAC3 (0.67) MMP1HDAC1HDAC3HDAC2HDAC8
SCHEMBL1233776 0.84 BMP1 (0.68) MMP1HDAC1HDAC3HDAC2HDAC8
SCHEMBL1233906 0.84 HDAC1 (0.66) MMP1HDAC1HDAC3HDAC2NCOR2
SCHEMBL14260747 0.83 HDAC1 (0.67) HDAC1HDAC3HDAC2HDAC8HDAC4
SCHEMBL1231831 0.83 HDAC3 (0.63) MMP1HDAC1HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 MMP1 959/4885HDAC1 1/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.